Analysis of prevalence and predictive factors of long-lasting olfactory and gustatory dysfunction in COVID-19 patients

MA Callejón-Leblic, DI Martín-Jiménez… - Life, 2022 - mdpi.com
Background: Although smell and taste disorders are highly prevalent symptoms of COVID-
19 infection, the predictive factors leading to long-lasting chemosensory dysfunction are still …

Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders

SR Hunter, ME Hannum, R Pellegrino… - Chemical …, 2023 - academic.oup.com
Abstract It is estimated that 20%–67% of those with COVID-19 develop olfactory disorders,
depending on the SARS-CoV-2 variant. However, there is an absence of quick, population …

Impairment of quality of life due to COVID-19-induced long-term olfactory dysfunction

AL Winter, S Henecke, JN Lundström… - Frontiers in …, 2023 - frontiersin.org
Introduction Olfactory dysfunction is one of many long-lasting symptoms associated with
COVID-19, estimated to affect approximately 60% of individuals and often lasting several …

Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia

R Sekine, AK Hernandez, C Overbeck… - The …, 2024 - Wiley Online Library
Objectives This study aimed to determine the characteristics of patients with qualitative
olfactory dysfunction (qualOD) and whether individuals with parosmia exhibit increased …

Platelet‐Rich Plasma for Treating COVID‐19‐Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study

JR Lechien, S Saussez - Otolaryngology–Head and Neck …, 2025 - Wiley Online Library
Objective To investigate the effectiveness of platelet‐rich plasma (PRP) injection into the
olfactory clefts of coronavirus disease 2019 (COVID‐19) patients with persistent anosmia …

[HTML][HTML] Prevalencia de la COVID persistente: seguimiento al año de una cohorte poblacional ambulatoria

M Carrera-Morodo, A Pérez-Orcero… - Revista Clínica de …, 2023 - SciELO Espana
Antecedentes y objetivo: la evolución a largo plazo en pacientes con COVID-19 no es
suficientemente conocida. El objetivo es estimar la prevalencia de la COVID persistente …